MAKING GREAT DRUGS BETTER

News

Re-Vana Announces Two New Team Appointments 

RE-Vana Therapeutics CEO Michael J. O'Rourke announces two new team appointments: Following our successful $11.9M Series A in November 2022, Re-Vana Therapeutics is delighted to further strengthen our team with two new appointments as we develop our sustained release...

read more

ExSight Ventures discuss why they invested into Re-Vana

In the OIS Podcast, ExSight Ventures discuss why they invested into Re-Vana. Here is the segment where they discuss Re-Vana Therapeutics:  Download the excerpt using this link.Listen to the Full Podcast Here (Discussion of Re-Vana commences at 43 minutes.)...

read more